Copyright
©The Author(s) 2019.
World J Cardiol. Jan 26, 2019; 11(1): 38-46
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.38
Published online Jan 26, 2019. doi: 10.4330/wjc.v11.i1.38
Figure 1 Kaplan-Meir graph showing post-transplant survival in familial dilated cardiomyopathy, non-ischemic cardiomyopathy, and ischemic cardiomyopathy patients.
One, three, and five years post-transplant survival of patients with FDCM (91%, 88%, and 80%) was similar to those with NICM (91%, 84%, 79%, P = 0.225), but superior to those with ICM (89%, 82%, 75%, P = 0.008), respectively. NICM: Non-ischemic cardiomyopathy; FDCM: Familial dilated cardiomyopathy; ICM: Ischemic cardiomyopathy.
- Citation: Khayata M, Al-Kindi SG, Oliveira GH. Contemporary characteristics and outcomes of adults with familial dilated cardiomyopathy listed for heart transplantation. World J Cardiol 2019; 11(1): 38-46
- URL: https://www.wjgnet.com/1949-8462/full/v11/i1/38.htm
- DOI: https://dx.doi.org/10.4330/wjc.v11.i1.38